1643.HK Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 birž. 2024 @ 10:38):
Our systems believe the stock currently is overvalued by -0.03% compare to its pairs and should correct downwards.

Modern Chinese Medicine Group Co., Ltd., an investment holding company, produces and sells proprietary Chinese medicines for elderlies and aged-middle in the People's Republic of China...

Stats
Šios dienos apimtis	27 000
Vidutinė apimtis	226 406
Rinkos kapitalizacija	240.00M
EPS	HKD0.0382 ( Q4 \| 2023-12-31 )
Last Dividend	HKD0.0167 ( 2022-05-25 )
Next Dividend	HKD0 ( N/A )
P/E	4.44 (Sector) 14.27 (Industry) 0
ATR14	HKD0 (0.00%)

1093.HK -1.74%

1643.HK 8.11%

1666.HK 1.61%

3933.HK -0.24%

Koreliacija (AI algo v.1.1b): Overvalued: -0.03% HKD0.400 paired level. (Algoritmas realiuoju laiku stebi didžiausią koreliaciją turinčių akcijų pokyčius ir suteikia momentinę informaciją)

Modern Chinese Medicine Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Modern Chinese Medicine Finansinės ataskaitos

Annual	2023
Pajamos:	HKD344.08M
Bruto pelnas:	HKD104.18M (30.28 %)
EPS:	HKD0.0813

FY	2023
Pajamos:	HKD344.08M
Bruto pelnas:	HKD104.18M (30.28 %)
EPS:	HKD0.0813

FY	2022
Pajamos:	HKD399.66M
Bruto pelnas:	HKD170.79M (42.73 %)
EPS:	HKD0.150

Financial Reports:

No articles found.

Modern Chinese Medicine Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

Modern Chinese Medicine Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.59 - Potential for dividend initiation, but uncertain (11.83%)

Information

First Dividend	HKD0.0167	2022-05-25
Last Dividend	HKD0.0167	2022-05-25
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	HKD0.0167	--
Avg. Dividend % Per Year	0.00%	--
Score	2.93	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	5.59
Div. Directional Score	9.74	--

Next Divdend (Est)
(2024-06-30)

HKD0 Estimate 0.00 %

Dividend Stability

0.03 Very Bad

Dividend Score

2.93

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Dividend History

Ex Date	Amount	Declaration Date	Record Date	Payment Date
25 May 2022	HKD0.0167	30 Nov -0001	30 Nov -0001	30 Nov -0001

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
3848.HK	Ex Dividend Junior	2023-07-04	Annually	0.00%
0896.HK	Ex Dividend Junior	2023-07-05	Semi-Annually	0.00%
2191.HK	Ex Dividend Knight	2023-08-30	Semi-Annually	0.00%
0467.HK	Ex Dividend Junior	2023-07-18	Annually	0.00%
1691.HK	Ex Dividend Knight	2023-09-13	Annually	0.00%
0086.HK	Ex Dividend Knight	2023-08-31	Semi-Annually	0.00%
6886.HK	Ex Dividend Junior	2023-07-12	Annually	0.00%
1126.HK	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
2607.HK	Ex Dividend Junior	2023-07-18	Annually	0.00%
0709.HK	Ex Dividend Knight	2023-09-05	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.159	1.500	6.83	10.00	[0 - 0.5]
returnOnAssetsTTM	0.183	1.200	3.90	4.69	[0 - 0.3]
returnOnEquityTTM	0.209	1.500	8.79	10.00	[0.1 - 1]
payoutRatioTTM	0.00736	-1.000	9.93	-9.93	[0 - 1]
currentRatioTTM	8.93	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	7.96	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	5.86	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.000136	-1.500	10.00	-10.00	[0 - 0.6]
interestCoverageTTM	9 967.60	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	0.135	2.00	9.95	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.113	2.00	9.94	10.00	[0 - 20]
debtEquityRatioTTM	0.000152	-1.500	10.00	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.344	1.000	7.60	7.60	[0.2 - 0.8]
operatingProfitMarginTTM	0.239	1.000	7.23	7.23	[0.1 - 0.6]
cashFlowToDebtRatioTTM	1 126.05	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	1.153	0.800	5.65	4.52	[0.5 - 2]
Total Score				13.90

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	2.48	1.000	9.85	0	[1 - 100]
returnOnEquityTTM	0.209	2.50	9.22	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.113	2.00	9.96	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.135	2.00	9.95	10.00	[0 - 30]
payoutRatioTTM	0.00736	1.500	9.93	-9.93	[0 - 1]
pegRatioTTM	0.189	1.500	-2.07	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.133	1.000	9.17	0	[0.1 - 0.5]
Total Score				5.59

Modern Chinese Medicine Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Modern Chinese Medicine

Modern Chinese Medicine Group Co., Ltd., an investment holding company, produces and sells proprietary Chinese medicines for elderlies and aged-middle in the People's Republic of China. It offers therapeutics for the qi-deficiency and blood-statis, cardio-cerebrovascular, digestive and gastrointestinal, gynecological, respiratory system, and nervous system conditions. The company was founded in 1986 and is headquartered in Chengde, China. Modern Chinese Medicine Group Co., Ltd. is a subsidiary of Modern Biotechnology Group Holdings Co., Ltd.